Shan Fang, Linglin Zhang, Peiru Wang, Lei Shi, Haiyan Zhang, Caihe Liao, Zijun Zhao, Zongxia Zhou, Yan Zhao, Guorong Yan, Yun Wu, Yuhao Wu, Zhe Zheng, Ruiping Wang, Yeqiang Liu, Guolong Zhang, Xiuli Wang
BACKGROUND: Photodynamic therapy (PDT) has been strongly recommended as an excellent alternative treatment for Bowen's disease (BD). However, reported data on 5-aminolevulinic acid-mediated PDT (ALA-PDT) with red light irradiation are limited and the long-term effectiveness remains to be determined, especially in dark-skinned populations. METHODS: Medical records of BD patients who received ALA-PDT with red light irradiation between February 2011 and June 2021 were reviewed and summarized...
April 20, 2024: Clinical and Experimental Dermatology